Revolution Medicines director Elizabeth M. Anderson disposes of $1,949,321.86 in common shares
Bitget2026/09/24 22:00- Elizabeth M. Anderson, director, cut her direct stake in Revolution Medicines common stock to 4,333 shares on Sep. 22, 2026.
- The change followed option exercise of 5,070 shares at USD 1.12, then sales totaling 10,143 shares at USD 191.8521-USD 195.15.
- Derivative holdings fell to 1,095 stock options exercisable at USD 1.12, expiring Apr. 19, 2028.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Raphael Zagury: Bitcoin will eventually surpass gold
Federal Reserve Bowman: AI Brings Both Opportunities and Risks to the Banking Industry, Fed Urges Strengthening of System Security Protections
Federal Reserve Vice Chair for Supervision, Bowman, warned that AI has a dual impact on the banking industry, serving both as a defensive tool and introducing new emerging risks. She urged banks to strengthen basic cybersecurity measures, including updating asset inventories, deploying multi-factor authentication, and improving vulnerability management. Bowman also stated that regulators will continue to adjust their examination approaches, implementing differentiated supervision for community banks instead of imposing blanket mandatory requirements.
FingerMotion to Buy Newbit Technology for $2.3 Million
BUZZ - Pyxis Oncology shares decline after launching equity financing
Crypto prices
More
